Increased MLF1 as an oncogene expression has been correlated with a poor prognosis in AML and with malignant progression in MDS [57, 58]; however, it was significantly down-regulated in THCA (Figure 4G) and expressed at a lower level in the high risk group than in the low risk group (Figure 3H). Here, MLF1 is linked to myelodysplastic syndrome.